期刊文献+

APOE基因多态性与阿尔茨海默病的相关性研究 被引量:4

Association of Apolipoprotein E Polymorphism and Sporadic Alzheimer's Disease
下载PDF
导出
摘要 目的分析载脂蛋白E(APOE)基因多态性是否与散发性阿尔茨海默病(AD)存在关联;探讨APOE基因多态性对血脂、脂蛋白代谢的影响及在AD发病中的作用。方法运用多重引物等位特异PCR法检测77例散发性AD患者和158例非痴呆(ND)对照组中APOE基因型和等位基因频率;简易智能精神状态检查量表对AD研究对象进行评分,并测定血浆中的TC,TG,HDL-C,LDL-C,apoE,apoA和apoB的浓度。结果①AD和ND组携带ε4的基因型频率分别为20.8%和9.5%,两组差别有统计学意义(X^2=5.758,P=0.016,OR=2.501,95%CI为1.163-5.376);APOEε4等位基因频率AD组(11.7%)高于ND对照组(5.1%),差异具有统计学意义(X^2=6.772,P=0.009)。②AD组血浆TC,HDL-C,LDL-C,apoE,apoB水平均明显低于ND组(P均等于0.000);血浆TG和apoA水平在两组中差异无统计学意义;APOEε2,ε3和ε4组间血浆TC,TG和HDL-C水平差异有统计学意义;与ε3相比,ε4使TC和HDL-C水平降低,TG水平升高,ε2则使TC和TG水平降低,HDL-C水平升高,提示APOE基因型调控血脂的代谢。③校正年龄、性别后,APOEε4等位基因是AD发生的危险因素(OR=3.990,95%CI为1.527-10.425,P=0.005);HDL-C则是AD的保护因素(OR=0.062,95%CI为0.014-0.270,P=0.000);携带APOEε4的基因型与HDL-C无交互作用(HDL-C * genotype P=0.596)。结论APOEε4等位基因,HDL-C与散发性AD有关联,APOEε4可能是散发性AD发病的危险因素,并建议把APOEε4和HDL-C等作为散发性AD的生物标记。 Objective To explore whether the polymorphism of apolipoprotein E (APOE) gene are associated with sporadic Alzheimer's Disease(AD),and whether influence of APOE genotypes on lipids and apolipoprotein metabolism and it is a risk of sporadic AD. Methods APOE genotypes were analyzed by using multi allele-specific primer PCR. Mini-Mental State Examination scores for both patients with AD and ND subjects. The concentration of serum TC,TG,HDL-C,LDL- C,apoE,apoA and apoB were measured in fasting blood samples. Results①APOE ε4 genotype frequency was in AD subjects(20.8%) was significantly higher than in ND subjects (9.5%)(X^2=5.785,P=0.016,OR=2. 501,95% CI 1.163-5.376). Allele frequency of APOE E4 was in AD subjects (11.7%) was significantly higher than in ND subjects (5.1%) (X^2= 6.772,P=0.009). ②The concentration of serum TC,HDL-C,LDL-C,apoE and apoB in AD subjects were significant lower than in ND subjects (all P=0.000). The concentration of TG and apoA were not statistical difference between sporadic AD and ND (P〉0.05). The concentration of serum TC,TG and HDL-C were statistically significant differences in the subjects with APOE ε2 ,ε3 and ε4. APOE ε4 allele had been associated with high TG level and with a decreased level of TC and HDL-C relative to ε3 allele,but the APOE ε2 allele had been associated with high HDL-C level and with a decreased level of TC and TG relative to ε3 allele. Data suggested APOE genotypes probably regulated lipid and apolipoprotein metabolism. ③Controlling age and gender, Logistic regression analysis showed that APOE ε4 allele was a risk factor (OR=3.990,95% CI 1.527-10.425,P=0.005) and HDL-C was a protection factor (OR=0.062,95% CI 0.014-0.270,P=0.000) for sporadic AD. There was no interaction effect between APOE ε4 genotype and HDL-C(HDL-C * genotype P=0. 596). Conclusion Data suggest that APOE ε4 allele and HDL-C are associated with sporadic AD. APOE ε4 allele might be a risk factor in AD and play a major role in the onset of sporadic AD. The results suggest that APOE ε4 allele and HDL-C can be used as biomarkers of AD.
出处 《现代检验医学杂志》 CAS 2008年第2期20-23,共4页 Journal of Modern Laboratory Medicine
基金 昆明医学院第一附属医院科技基金资助项目(2007yn09)
关键词 载脂蛋白E 血脂 脂蛋白 基因多态性 散发性阿尔茨海默病 APOE lipids apolipoprotein polymorphism sporadic Alzheimer ' s disease
  • 相关文献

参考文献13

  • 1Lahiri DK. Apolipoprotein E as a target for developing new therapeutics for Alzheimer's disease based on studies from protein, RNA,and regulatory region of the gene [J]. J Mol Neurosci, 2004, 23 (3):225- 233.
  • 2Jacob Raber,Yadong Huang,J Wesson Ashford. APOE genotype accounts for the vast majority of AD risk and AD pathology[J]. Neurobiology of Aging, 2004,25:641-650.
  • 3Donohoe GG, Salomaki A, Lehtimaki T, et al. Rapid identification of apolipoprotein E genotypes by multiplex amplification refractory mutation system PCR and capillary gel eleetrophoresis[J]. Clin Chem, 1999,45(1) : 143-146.
  • 4Harris FM, Brecht WJ,Xu Q,et al. Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer disease-like neurodegeneration and behavioral deficits in transgenic mice[J]. Proc Natl Acad Sci USA, 2003, 100:10966-10971.
  • 5Souza DR,de Godoy MR,Hotta J,et al. Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians[J]. Braz J Med Biol Res,2003,36(7):919-923.
  • 6Hallman D M,Boerwinkle E,Saha N,et al. The apolipoproteln E polymorphlsm:a comparison of allele frequencies and effects in nine populations[J]. Am J Hum Genet, 1991,49 : 338-349.
  • 7Venkatramane P,Chengal R,Ferrell R E,et al. Apollpoprotein E polymorphlsm among the Indian populations and its comparison with other Asian populations[J]. IJHG, 2001,1 (2) : 123-128.
  • 8Romas SN ,Tang MX ,Berglund L ,et al. APOE genotype, plasma llpids, lipoproteins, and AD in community elderly[J]. Neurology, 1999,53 : 517-521.
  • 9Colin J Barrow,David H Small. Abeta peptide and Alzheimer' s disease : celebrating a century of research[M]. London:Springer-Verlag London Limited, 2007 ; 142
  • 10Solfrizzi V,Panza F,D'Introno A, et al. Lipoprotein (a), apolipoprotein E genotype, and risk of Alzheimer's disease [J ]. J Neurol Neurosurg Psychiatry, 2002,72 : 732-736.

同被引文献108

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部